About
Global Health Ltd
Global Health Limited was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Limited Company under the Companies Act, 1956. The Company converted into a Public Limited Company, passed by Shareholders at the EGM held on July 31, 2021 and consequently, name of the Company was changed to Global Health Limited' dated August 11, 2021 issued by the RoC.
The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the 'Medanta' brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients.
In November 2009, the Company opened its flagship hospital in Gurugram.
In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna.
In 2019, it commenced operations of new hospital at Lucknow.
In 2020, Patna hospital's outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022.
The Company has taken in-house facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds.
In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO)
The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.
The Company's Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow hospital also added seven new OTs and have hired over 50 senior clinicians. Towards the end of FY23, Lucknow hospital commissioned the Siemens Varian EDGE Radiation Oncology machine - the first in North India - as well as set up a dedicated e-ICU Command Centre to assist in remote critical care management. The Company's Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23, the Company also announced a new 300- bed hospital project in Indore under the asset-light O&M model. It started Medanta Labs in January 2023. During the year 2022-23, GHL Pharma was incorporated as a wholly-owned subsidiary on June 29, 2022.
Global Health Ltd
Chairman Speech
Dear shareholders,
It is a privilege and honour for me to share my thoughts with you in our maiden Annual
Report post listing. First and foremost, I want to extend my heartfelt gratitude to all
our stakeholders who have been an integral part of this extraordinary journey — our
patients, doctors, team members, partners and the entire capital market fraternity. Your
unwavering support and trust have been instrumental in transforming Medanta into the
beacon of hope and excellence it is today. We value the trust you have reposed in us and
look forward to your support in our journey forward.
It is worthwhile to take a step back and reflect on the remarkable advancement in the
delivery of healthcare services in India. Decades ago, the number of Indians seeking
advanced medical treatments overseas highlighted the stark absence of cutting-edge
healthcare facilities in our own nation. Recognising this disparity during my time as a
cardiac surgeon in the US, I was inspired to create a cardiac hospital that would offer
the most advanced cardiac treatments at a fraction of global costs and my journey back to
India started.
On my return to India, we built the largest standalone Heart Institute in the world in
Delhi; however, it gradually became clear to me that patients were not getting the best
treatment across all specialties. Thus, the idea of Medanta, the Medicity, was
conceptualised and took shape with our first campus in Gurugram spreading across 43 acres,
bringing all medical specialties together on a common platform similar to the quality
standards of US and Europe.
At Medanta Gurugram, we have built a destination care hospital with approximately 1,400
beds and 40 operating theatres, which matches the highest benchmarks of excellence, and
are fully equipped to deliver high-end quaternary care. We have created an ecosystem of
excellence that encompasses world-leading clinicians, state-of-the-art equipment,
best-in-class infrastructure and a strong emphasis on research and innovation. Medanta's
patient-first approach allows teams of super-specialist doctors to collaborate seamlessly
and arrive at the best-possible treatment, customised for each patient in line with our
guiding philosophy ‘Har Ek Jaan Anmol', meaning ‘Every Life is Invaluable'.
Over the years, we have remained committed to providing the highest end of care that
can rival the best in the world. We have evolved a doctor-led model, driven by skilled and
experienced doctors, who are among the best in their specific area of specialisation.
Autonomy is given to each departmental head to drive clinical practice and to ensure the
focus is on the highest standard of healthcare. As we continue our legacy of clinical
excellence, we have been recognised as the best private hospital in India for a fourth
consecutive year by a reputed and independent platform like Newsweek. This is a testimony
to the standard of clinical care we deliver across our hospital network.
Serving the underserved markets
Our mission has evolved to democratise healthcare and address the underserved regions
in our country. India's healthcare infrastructure still faces significant challenges, with
rural areas suffering the most. Most of the high-quality healthcare infrastructure is
concentrated in metro cities. Therefore, to bridge this gap, we have established two more
greenfield facilities in Lucknow and Patna with a potential bed capacity of 950 and 650
beds, respectively.
We have brought the destination care hospital concept to Uttar Pradesh and Bihar with
both states ranking 1 and 2, respectively in terms of population, while lacking in terms
of critical care healthcare infrastructure. With our facilities in these regions, we can
serve 350+ million people and provide high-quality, cost-effective multi-specialty medical
services, while ensuring the same level of care and compassion.
Today, we are proud to be recognised as one of the largest private multi-specialty
tertiary care providers in Northern and Eastern India. Behind this achievement stands a
dedicated and compassionate team of doctors, nurses, paramedics and management
professionals, who ensure that every individual receives the highest quality care.
Indian healthcare at an inflection point
If we look at the current Indian healthcare ecosystem, I believe that healthcare
delivery in India has evolved significantly over the years and today we are at an
inflection point with tremendous healthcare opportunities ahead of us. The demand for
high-quality tertiary and quaternary care continues to gain momentum, driven by various
factors such as rising per capita income, increasing insurance penetration, a surge in
medical tourism and a rise in the adoption of telemedicine. The COVID-19 pandemic has
further contributed to increasing awareness about the importance of health and has
triggered a surge in the demand for high-quality healthcare infrastructure. While India
continues to remain one of the youngest countries, the elderly population is expected to
touch 200 million in 2030. A combination of all these factors is expected to further
increase the demand for quality healthcare, going forward.
New government policies such as Ayushman Bharat and Pradhan Mantri Suraksha Bima
Yojana, along with the increased budget allocation indicates that the government is likely
to play a greater role as health financier. The private sector will likely continue to be
the mainstay of providing tertiary and quaternary care in India. This presents a massive
opportunity for the private sector to play a pivotal role in delivering quality healthcare
accessible at an affordable cost to the masses and to all parts of country. As a result,
once again, we are seeing strong interest from private capital equity players in Indian
healthcare.
Digital innovation has emerged as a key enabler in bridging the accessibility gap in
healthcare services and it will revolutionise the way healthcare is accessed in our
country in the coming years. At Medanta, digitalisation is a core part of our long-term
strategy; we are ahead of the curve when it comes to creating and adopting digital
solutions. As part of our digital transformation efforts, we continuously enhance our
clinical applications to improve patient convenience. Our doctors benefit from the EMR
app, which allows them to access patient records from anywhere, receive real-time clinical
alerts and communicate with their teams in real-time. Our commitment to digital innovation
led to the development of our ‘smart nursing application,' which identifies critical
patients and empowers nurses with intelligent support based on predefined parameters.
Additionally, with a vision to enhance access to critical care in underserved regions,
Medanta has launched a Tele-ICU command centre in Uttar Pradesh, which was inaugurated by
the honourable Chief Minister, Shri. Yogi Adityanath. The initiative is aimed at
transforming healthcare delivery and addressing existing gaps in critical care through
high-level knowledge transfer and a 24x7 command centre that will enable round-the-clock
decision-making support in ICUs across Tier 2 and Tier 3 cities, where the availability of
intensivists and specialty care nurses is limited. This is in line with our philosophy
that healthcare is a necessity, not a luxury; therefore, it should be inclusive and
accessible to all.
Sustainability at the core
Sustainability is deeply embedded in Medanta, evident in our healthcare delivery
platform's conceptualisation. Our commitment to sustainability is reflected in multiple
aspects, including our environment-friendly and patient-centric infrastructure,
department-led doctor engagement model, growing presence in underserved markets and using
digital tools to bring quality healthcare closer to patients in remote areas. Overall, as
a healthcare service provider, we are conscious of giving back to the society in which we
operate and therefore, ‘Mission TB Free Haryana' was launched in November 2015 in
public private partnership between the Government of Haryana and Medanta Hospital to
increase access to TB diagnostic care in rural Haryana. Medanta has introduced a model to
improve the diagnosis of tuberculosis in the underserved rural areas, in order to
eradicate or at least substantially reduce the burden of this deadly disease. During the
year, we have screened over 5 lakh individuals across 4 districts of Haryana, identified
250+ cases and helped these patients start their medication. In the coming year, we are
planning to launch the TB free programme in Lucknow and Ranchi and simultaneously we
continue to encourage other partners to join the battle against TB.
Purpose-driven growth
Looking ahead, we have an exciting strategic roadmap laid out for Medanta. We already
have a planned bed build-out strategy for our existing hospitals in Lucknow and Patna. Our
Noida hospital is under construction and should be operational by the end of FY25, serving
the attractive micro-market of Noida and catering to western Uttar Pradesh. During the
year, we have also announced an asset-light partnership in Indore, where our partner will
build a 300-bed facility according to our specifications and Medanta will leverage its
experience in the region to further consolidate its market position in central India.
As a group, we continue to explore territories where we can make a difference in the
standard of healthcare delivery and we are committed to taking Medanta's standard of care
to as many communities as possible in the coming years. Moreover, we constantly seek
opportunities to make a difference in the continuum of care and extend our services beyond
the hospital setting. Our outpatient pharmacy business, lab business and home care
business are all part of our efforts to provide patients with an integrated and
comprehensive healthcare experience.
At Medanta, patient well-being is at the heart of our strategy. Our infrastructure,
technology, clinical expertise and compassionate approach are all aligned to ensure the
best outcomes for our patients. We will capitalise on growth opportunities, diversify into
new services, including digital health and make a real difference in people's lives. Our
core belief in the human side of healthcare sets us apart. We not only provide the highest
level of care but also foster human connections, putting the patient first and making them
feel safe and secure. These values and acts of empathy will continue to guide our
decision-making as we forge ahead.
In conclusion, I extend my deepest gratitude once again to all our shareholders and
stakeholders for being an integral part of this transformative journey. Your unwavering
support and trust inspire us to continually raise the bar and redefine healthcare
standards in India. Together, we will shape a healthier and brighter future for our
nation.
| Thank you. |
| Dr. Naresh Trehan |
| Chairman & Managing Director |
  Â
Global Health Ltd
Company History
Global Health Limited was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Limited Company under the Companies Act, 1956. The Company converted into a Public Limited Company, passed by Shareholders at the EGM held on July 31, 2021 and consequently, name of the Company was changed to Global Health Limited' dated August 11, 2021 issued by the RoC.
The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the 'Medanta' brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients.
In November 2009, the Company opened its flagship hospital in Gurugram.
In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna.
In 2019, it commenced operations of new hospital at Lucknow.
In 2020, Patna hospital's outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022.
The Company has taken in-house facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds.
In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO)
The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.
The Company's Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow hospital also added seven new OTs and have hired over 50 senior clinicians. Towards the end of FY23, Lucknow hospital commissioned the Siemens Varian EDGE Radiation Oncology machine - the first in North India - as well as set up a dedicated e-ICU Command Centre to assist in remote critical care management. The Company's Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23, the Company also announced a new 300- bed hospital project in Indore under the asset-light O&M model. It started Medanta Labs in January 2023. During the year 2022-23, GHL Pharma was incorporated as a wholly-owned subsidiary on June 29, 2022.